000 | 01986 a2200565 4500 | ||
---|---|---|---|
005 | 20250515035820.0 | ||
264 | 0 | _c20070117 | |
008 | 200701s 0 0 eng d | ||
022 | _a0006-4971 | ||
024 | 7 |
_a10.1182/blood-2006-05-024414 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHijiya, Nobuko | |
245 | 0 | 0 |
_aBody mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bBlood _cDec 2006 |
||
300 |
_a3997-4002 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMercaptopurine _xadministration & dosage |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTeniposide _xadministration & dosage |
700 | 1 | _aPanetta, John C | |
700 | 1 | _aZhou, Yinmei | |
700 | 1 | _aKyzer, Emily P | |
700 | 1 | _aHoward, Scott C | |
700 | 1 | _aJeha, Sima | |
700 | 1 | _aRazzouk, Bassem I | |
700 | 1 | _aRibeiro, Raul C | |
700 | 1 | _aRubnitz, Jeffrey E | |
700 | 1 | _aHudson, Melissa M | |
700 | 1 | _aSandlund, John T | |
700 | 1 | _aPui, Ching-Hon | |
700 | 1 | _aRelling, Mary V | |
773 | 0 |
_tBlood _gvol. 108 _gno. 13 _gp. 3997-4002 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2006-05-024414 _zAvailable from publisher's website |
999 |
_c16503787 _d16503787 |